Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of N-Benzylmethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.50 |
| ▸ | SIGMAR1 known ✓ | Q99720 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.50 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
| ▸ | ADH1A | P07327 | 1/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Benzylmethylamine SCHEMBL27370226 | 1.00 | MAPT (1.00) | MAPTCYP3A4KDM4EATMTAAR1 | |
| N-Benzylmethylamine SCHEMBL28173950 | 1.00 | MAPT (1.00) | MAPTCYP3A4KDM4EATMTAAR1 | |
| N-Benzylmethylamine SCHEMBL23581071 | 0.97 | MAPT (0.95) | MAPTCYP3A4KDM4EATMTAAR1 | |
| N-Benzylmethylamine SCHEMBL11638857 | 0.97 | MAPT (0.95) | MAPTCYP3A4KDM4EATMTAAR1 | |
| N-Benzylmethylamine SCHEMBL2271 | 0.97 | — | — | |
| N-Benzylmethylamine SCHEMBL11696446 | 0.97 | CYP3A4 (0.94) | MAPTCYP3A4KDM4EATMTAAR1 | |
| SCHEMBL24334039 | 0.97 | CYP3A4 (0.94) | MAPTCYP3A4KDM4EATMTAAR1 | |
| N-Benzylmethylamine SCHEMBL4609847 | 0.97 | CYP3A4 (0.94) | MAPTCYP3A4KDM4EATMTAAR1 | |
| N-Benzylmethylamine SCHEMBL8083805 | 0.94 | — | — | |
| N-Benzylmethylamine SCHEMBL9346326 | 0.94 | CYP3A4 (0.90) | MAPTCYP3A4KDM4EATMTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1923 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081951-A | Corrosion inhibitor for circulating water of coastal high-chlorine environment steel mill and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12614726-B2 | Dispersion and stabilization of MXene materials and MXene materials for energy storage applications | DREXEL UNIVERSITY (US) | 2026-04-28 | — | — | US | claimed |
| CN-118375018-A | Paving method of high-viscosity asphalt ultrathin cover layer | 深圳市路桥建设集团有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-114191332-B | Hair mask with shape memory function and preparation method thereof | 上海自然堂集团有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117736369-A | Reverse microemulsion thickener, preparation method and non-crosslinked recyclable fracturing fluid | 陕西延长石油（集团）有限责任公司 | 2024-03-22 | — | — | CN | claimed |
| US-20240058434-A1 | NANOEMULSION UNIVERSAL INFLUENZA VACCINE | BLUEWILLOW BIOLOGICS, INC. (US) | 2024-02-22 | — | — | US | claimed |
| WO-2023200764-A1 | NANOEMULSION UNIVERSAL INFLUENZA VACCINE | BLUEWILLOW BIOLOGICS, INC. (US) | 2023-10-19 | — | — | WO | claimed |
| CN-116832227-A | Preparation method and application of substrate surface adhesion electrostatic complex coating | 征鸿诺瓦医疗科技(深圳)有限公司 | 2023-10-03 | — | — | CN | claimed |
| WO-2023133143-A1 | INTRANASAL POLYSACCHARIDE CONJUGATE NANOEMULSION VACCINES AND METHODS OF USING THE SAME | BLUEWILLOW BIOLOGICS, INC. (US) | 2023-07-13 | — | — | WO | claimed |
| US-11648337-B2 | Drug-coated balloon catheters for body lumens | UROTRONIC, INC. (US) | 2023-05-16 | — | — | US | claimed |
| US-5374536-A | Adding known quantity of microbe contaminated water, nutrient, oxidation-reduction indicator to series of sample wells, adding serial dilution of first and second microbiocides, incubating, comparing color change | NALCO CHEMICAL COMPANY (US) | 1994-12-20 | — | — | US | claimed |
| EP-0615857-A1 | Recording sheets containing monoammonium compounds | XEROX CORPORATION (US) | 1994-09-21 | — | — | EP | claimed |
| US-5320902-A | Suitable for use in ink jet printing | XEROX CORPORATION (US) | 1994-06-14 | — | — | US | claimed |
| WO-1994012460-A1 | PROCESS FOR PREPARING SUBSTANTIALLY PURE ENANTIOMERS OF PHENYLPROPIONIC ACIDS | THE BOOTS COMPANY PLC (GB) | 1994-06-09 | — | — | WO | claimed |
| EP-0505023-A1 | Synergistic, additive or antagonistic product selection test for biocides | NALCO CHEMICAL COMPANY (US) | 1992-09-23 | — | — | EP | claimed |
| EP-0358856-A2 | Novel insecticidal dibenzoyl-tert-butylcarbanonitrile compounds and method for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1990-03-21 | — | — | EP | claimed |
| US-4857550-A | Novel insecticidal dibenzoyl-tert-butylcarbazonitrile compounds and method for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1989-08-15 | — | — | US | claimed |
| US-4800235-A | MICROBIOCIDES | NALCO CHEMICAL COMPANY (US) | 1989-01-24 | — | — | US | claimed |
| EP-0252278-A2 | Disinfecting agents and their use in disinfecting the skin and mucous membranes | Henkel Kommanditgesellschaft auf Aktien (DE) | 1988-01-13 | — | — | EP | claimed |
| US-4076765-A | MOLDING MATERIALS, CONSTRUCTION MATERIALS | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-02-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12614726-B2 | Dispersion and stabilization of MXene materials and MXene materials for energy storage applications | SLC10A6, SLC9A2, SLC6A19 | GAA 4182/4885SIGMAR1 158/4885MAPT 3721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.